Healthcare >> CEO Interviews >> June 2, 2003
DR. MITCHELL H. GOLD is President and Chief Executive Officer of
Dendreon Corporation. Dr. Gold joined Dendreon in 2001 as Vice President
of Business Development and was later promoted to Chief Business Officer
and then to CEO in January 2003. Dr. Gold has led the company's
corporate development, acquisition and financing efforts in recent
years, completing transactions valued at approximately $225 million,
including the recent acquisition of Corvas International, and raising
over $200 million in capital. Prior to joining Dendreon, he served as
Vice President of Business Development for Data Critical Corporation,
now a division of GE Medical. He also served as co-Founder, President
and CEO of Elixis Corporation, a leader in healthcare information
services. Dr. Gold is a former Urologist at the University of Washington
and currently serves on the Boards of the University of Washington/Fred
Hutchinson Cancer Research Center Prostate Cancer Institute and Xenotope
Diagnostics of San Antonio, Texas. Dr. Gold received his BS from the
University of Wisconsin-Madison and his MD from Rush Medical College. Profile
Dr. Gold: Dendreon was originally started in the early 1990s out
of Sam Strober's and Ed Engleman's lab at Stanford University.
Its
